NO20005223L - Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen - Google Patents

Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen

Info

Publication number
NO20005223L
NO20005223L NO20005223A NO20005223A NO20005223L NO 20005223 L NO20005223 L NO 20005223L NO 20005223 A NO20005223 A NO 20005223A NO 20005223 A NO20005223 A NO 20005223A NO 20005223 L NO20005223 L NO 20005223L
Authority
NO
Norway
Prior art keywords
inflammatory bowel
bowel disease
composition
acetylglucosamine
colon
Prior art date
Application number
NO20005223A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005223D0 (no
Inventor
Simon Murch
Ian W French
Original Assignee
Glucogenics Pharmaceuticals In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA1999/000218 external-priority patent/WO1999053929A1/fr
Application filed by Glucogenics Pharmaceuticals In filed Critical Glucogenics Pharmaceuticals In
Publication of NO20005223D0 publication Critical patent/NO20005223D0/no
Publication of NO20005223L publication Critical patent/NO20005223L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
NO20005223A 1998-04-17 2000-10-17 Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen NO20005223L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002234936A CA2234936C (fr) 1998-04-17 1998-04-17 Composition pour traiter une affection intestinale inflammatoire par l'administration de n-acetylglucosamine par le colon et traitement connexe
PCT/CA1999/000218 WO1999053929A1 (fr) 1998-04-17 1999-03-12 Composition et methode permettant de traiter les affections inflammatoires de l'intestin par administration intra-colique de n-acetylglucosamine

Publications (2)

Publication Number Publication Date
NO20005223D0 NO20005223D0 (no) 2000-10-17
NO20005223L true NO20005223L (no) 2000-11-20

Family

ID=4162337

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005223A NO20005223L (no) 1998-04-17 2000-10-17 Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen

Country Status (8)

Country Link
EP (1) EP1071432A1 (fr)
JP (1) JP2002512195A (fr)
CA (1) CA2234936C (fr)
CZ (1) CZ20003846A3 (fr)
HU (1) HUP0101514A3 (fr)
IL (1) IL139072A0 (fr)
NO (1) NO20005223L (fr)
PL (1) PL343634A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008103345A2 (fr) 2007-02-19 2008-08-28 Marine Polymer Technologies, Inc. Compositions hémostatiques et régimes thérapeutiques
KR101098581B1 (ko) * 2009-01-09 2011-12-26 서울대학교산학협력단 Ａｂｈ 항원을 이용한 염증질환 개선용 조성물
CN103108638B (zh) 2010-04-15 2016-11-09 海洋聚合物技术公司 聚-n-乙酰葡萄糖胺纳米纤维的抗菌应用
WO2012142581A1 (fr) 2011-04-15 2012-10-18 Marine Polymer Technologies, Inc. Traitement de maladies avec des nanofibres de poly-n-acétylglucosamine
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
WO2014142938A1 (fr) * 2013-03-15 2014-09-18 Aihol Corporation Formulation pharmaceutique contenant un glycosaminoglycane
HUE049247T2 (hu) * 2014-11-26 2020-09-28 Evonik Operations Gmbh Etanol hatásával szemben ellenálló gyógyászati vagy táplálék-gyógyszerészeti kompozíció
KR102104507B1 (ko) * 2019-08-23 2020-04-24 브릿지바이오테라퓨틱스(주) 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법

Also Published As

Publication number Publication date
HUP0101514A3 (en) 2003-07-28
IL139072A0 (en) 2001-11-25
NO20005223D0 (no) 2000-10-17
PL343634A1 (en) 2001-08-27
EP1071432A1 (fr) 2001-01-31
CZ20003846A3 (cs) 2002-03-13
HUP0101514A2 (hu) 2001-11-28
JP2002512195A (ja) 2002-04-23
CA2234936A1 (fr) 1999-10-17
CA2234936C (fr) 2004-06-29

Similar Documents

Publication Publication Date Title
NO20052348L (no) Behandling av hemoragisk sjokk
AU2005202257C1 (en) Azacyclic compounds for use in the treatment of serotonin related diseases
NO20033617D0 (no) Fremgangsmåte for behandling av diabetes mellitus
MY120279A (en) Use of a celecoxib composition for fast pain relief
HK1070575A1 (en) Use of botulinum toxin for treating cardiovasculardiseases
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
TW200510349A (en) Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
NO20003051L (no) Metode for administrering av AspB28-humant insulin
SG148850A1 (en) Methods of treating vascular disease
WO2003105763B1 (fr) Prevention et/ou traitement de maladie enterique inflammatoire au moyen de peptides yy ou d'antagonistes de peptides yy
HK1086186A1 (en) Use of spongosine (2-methoxyadenosein) for preparing pharmaceutical for the treatment of pain
EP0957925A4 (fr) Traitement de l'arthrose par administration de poly-n-acetyl-d-glucosamine
ATE305469T1 (de) Sulfonsäure- oder sulfonylamino-n-(heteroaralkyl)-azaheterozyklyl midverbindungen
NO20024924L (no) Anvendelse av bradykardiale substanser ved behandling av myokardiale sykdommer i forbindelse med hypertrofi og nyemedikamentkombinasjoner
NO20055390L (no) Thorium-227 for anvendelse i radioterapi pa mykvevssykdommer
NO20005223L (no) Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen
BR0008443A (pt) Inibidores de aminotransferaseaminoácido-dependente de cadeia ramificada e seuuso no tratamento da retinopatia diabética
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
NO20042758L (no) Fremgangsmate for behandling av en pasient som krever analgesi.
TW200503666A (en) Treatment of type 1 diabetes with pde5 inhibitors
EP1447090B8 (fr) Utilisation d'hyaluronidase pour la prophylaxie et le traitement de maladies cardio-vasculaires
NO984974L (no) Middel som forbedrer pulmonar sirkulasjon
BR0111900A (pt) Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca
WO2003024394A3 (fr) Methode de traitement d'hyperplasie prostatique benigne et d'autres pathologies prostatiques benignes
RU2006138043A (ru) Способ лечения инсульта с применением введения дефибриногенизирующих средств для достижения специфического характера дефибриногенизации

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application